Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7513)
All Articles published online
|
Publishing Process of This Article
|
Jan 14, 2014 (publication date) through Nov 14, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ranieri G, Marech I, Lorusso V, Goffredo V, Paradiso A, Ribatti D, Gadaleta CD. Molecular targeting agents associated with transarterial chemoembolization or radiofrequency ablation in hepatocarcinoma treatment. World J Gastroenterol 2014; 20(2): 486-497 [PMID: 24574717 DOI: 10.3748/wjg.v20.i2.486] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i2/486.htm |
| Number | Citing Articles |
| 1 |
Jietong Zhong, Xinyu Zhang, Yaru Ruan, Yue Huang. Photobiomodulation therapy’s impact on angiogenesis and osteogenesis in orthodontic tooth movement: in vitro and in vivo study. BMC Oral Health 2024; 24(1) doi: 10.1186/s12903-023-03824-z
|
| 2 |
De-Dong Cao, Hui-Lin Xu, Liang Liu, Yong-Fa Zheng, Si-Fa Gao, Xi-Ming Xu, Wei Ge. Thalidomide combined with transcatheter artierial chemoembolzation for primary hepatocellular carcinoma: a systematic review and meta-analysis. Oncotarget 2017; 8(27): 44976 doi: 10.18632/oncotarget.16689
|
| 3 |
Chunli Wu, Xiaoping Geng, Shengyun Wan, Hui Hou, Fanzong Yu, Benli Jia, Lei Wang. Cecropin‐P17, an analog of Cecropin B, inhibits human hepatocellular carcinoma cell HepG‐2 proliferation via regulation of ROS, Caspase, Bax, and Bcl‐2. Journal of Peptide Science 2015; 21(8): 661 doi: 10.1002/psc.2786
|
| 4 |
Qu Xie, Yanzhen Yang, Weiyuan Hao, Cong Luo. Unleashing the potential: transarterial chemoembolization combined with intra-arterial infusion of bevacizumab for unresectable hepatocellular carcinoma. Clinical and Translational Oncology 2024; 26(12): 3075 doi: 10.1007/s12094-024-03498-1
|
| 5 |
Carmelo Laface, Palma Fedele, Felicia Maria Maselli, Francesca Ambrogio, Caterina Foti, Pasquale Molinari, Michele Ammendola, Marco Lioce, Girolamo Ranieri. Targeted Therapy for Hepatocellular Carcinoma: Old and New Opportunities. Cancers 2022; 14(16): 4028 doi: 10.3390/cancers14164028
|
| 6 |
C. Aubé, A. Bouvier, J. Lebigot, L. Vervueren, V. Cartier, F. Oberti. Radiological treatment of HCC: Interventional radiology at the heart of management. Diagnostic and Interventional Imaging 2015; 96(6): 625 doi: 10.1016/j.diii.2015.04.008
|
| 7 |
Qiaoxin Wei, Haiyang Zhou, Xinhui Hou, Xiaoping Liu, Sisi Chen, Xueying Huang, Yu Chen, Mei Liu, Zhongping Duan. Current status of and barriers to the treatment of advanced-stage liver cancer in China: a questionnaire-based study from the perspective of doctors. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02425-4
|
| 8 |
C. Aubé, A. Bouvier, J. Lebigot, L. Vervueren, V. Cartier, F. Oberti. Traitement radiologique du CHC : la radiologie interventionnelle au centre de la prise en charge. Journal de Radiologie Diagnostique et Interventionnelle 2015; 96(2): 180 doi: 10.1016/j.jradio.2015.04.002
|
| 9 |
Katrin Fuchs, Rafael Duran, Alban Denys, Pierre E. Bize, Gerrit Borchard, Olivier Jordan. Drug-eluting embolic microspheres for local drug delivery – State of the art. Journal of Controlled Release 2017; 262: 127 doi: 10.1016/j.jconrel.2017.07.016
|
| 10 |
Lizhi Xiao, Enhua Xiao. Blood oxygen level–dependent functional magnetic resonance imaging can evaluate the efficiency of transcatheter arterial chemoembolization in hepatocellular carcinoma. Journal of Interventional Medicine 2019; 2(1): 5 doi: 10.1016/j.jimed.2019.05.002
|
| 11 |
Carmelo Laface, Girolamo Ranieri, Felicia Maria Maselli, Francesca Ambrogio, Caterina Foti, Michele Ammendola, Marigia Laterza, Gerardo Cazzato, Riccardo Memeo, Giovanni Mastrandrea, Marco Lioce, Palma Fedele. Immunotherapy and the Combination with Targeted Therapies for Advanced Hepatocellular Carcinoma. Cancers 2023; 15(3): 654 doi: 10.3390/cancers15030654
|
| 12 |
Di Pan, Hao-Nan Liu, Peng-Fei Qu, Xiao Ma, Lu-Yao Ma, Xiao-Xiao Chen, Yu-Qin Wang, Xiao-Bing Qin, Zheng-Xiang Han. Progress in the treatment of advanced hepatocellular carcinoma with immune combination therapy. World Journal of Gastrointestinal Oncology 2024; 16(2): 273-286 doi: 10.4251/wjgo.v16.i2.273
Abstract(281) |
Core Tip(300) |
Full Article(HTML)(1957)
|
Full Article with Cover (PDF)-1277K(87)
|
Full Article (Word)-608K(17)
|
Audio-366K(22)
|
Peer-Review Report-195K(48)
|
Answering Reviewers-82K(44)
|
Full Article (PDF)-1010K(85)
|
Full Article (XML)-268K(59)
|
Times Cited (5)
|
Total Visits (3806)
|
Open
|
| 13 |
Girolamo Ranieri, Michele Ammendola, Ilaria Marech, Annamaria Laterza, Ines Abbate, Caroline Oakley, Angelo Vacca, Rosario Sacco, Cosmo Damiano Gadaleta. Vascular endothelial growth factor and tryptase changes after chemoembolization in hepatocarcinoma patients. World Journal of Gastroenterology 2015; 21(19): 6018-6025 doi: 10.3748/wjg.v21.i19.6018
|
| 14 |
Pedro Viveiros, Ahsun Riaz, Robert J. Lewandowski, Devalingam Mahalingam. Current State of Liver-Directed Therapies and Combinatory Approaches with Systemic Therapy in Hepatocellular Carcinoma (HCC). Cancers 2019; 11(8): 1085 doi: 10.3390/cancers11081085
|
| 15 |
Girolamo Ranieri, Carmelo Laface. Loco-Regional and Systemic Chemotherapies for Hepato-Pancreatic Tumors: Integrated Treatments. Cancers 2020; 12(10): 2737 doi: 10.3390/cancers12102737
|
| 16 |
Carmelo Laface, Mariarita Laforgia, Pasquale Molinari, Ippazio Ugenti, Cosmo Damiano Gadaleta, Camillo Porta, Girolamo Ranieri. Hepatic Arterial Infusion of Chemotherapy for Advanced Hepatobiliary Cancers: State of the Art. Cancers 2021; 13(12): 3091 doi: 10.3390/cancers13123091
|
| 17 |
Jiaye Long, Baoxiang Chen, Zhaohui Liu. Comparative efficacy and safety of molecular targeted agents combined with transarterial chemoembolization in the treatment of unresectable hepatocellular carcinoma: a network meta-analysis. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1179431
|
| 18 |
Li Wu, Jiayu Zhao, Hao Cai, Jiaqi Wang, Zhipeng Chen, Weidong Li, Xiao Liu, Yuewen Gong. Dahuang Zhechong Pill Combined with Doxorubicin Induces Cell Death through Regulating Energy Metabolism in Human Hepatocellular Carcinoma Cells. Evidence-Based Complementary and Alternative Medicine 2017; 2017(1) doi: 10.1155/2017/6279576
|
| 19 |
Changjiang Lei, Defa Ren, Meixia Fu, Chuantao Sun, Hong Ren, Qingyun Pan, Yuan Li. Curative effect of endostar combined with oxaliplatin in the treatment of primary hepatic carcinoma and its influence on immune cells. Oncology Letters 2019; doi: 10.3892/ol.2019.10022
|
| 20 |
Wentao Jia, Lina Wang, Michel Mansur Machado. Using Traditional Chinese Medicine to Treat Hepatocellular Carcinoma by Targeting Tumor Immunity. Evidence-Based Complementary and Alternative Medicine 2020; 2020(1) doi: 10.1155/2020/9843486
|